Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 63, Issue 4, 2005, Pages 1037-1044

  Dae, Ho Lee ^a   Han, Ji Youn ^a   Kwan, Ho Cho ^a   Hong, Ryull Pyo ^a   Hyae, Young Kim ^a   Sung, Jin Yoon ^a   Lee, Jin Soo ^a  

^a National Cancer Center   (South Korea)

Author keywords

Concurrent chemoradiotherapy; Gemcitabine; Induction chemotherapy; Non small cell lung cancer; Vinorelbine

Indexed keywords

BIOMEDICAL ENGINEERING; CARCINOGENS; CELLS; PATIENT TREATMENT; TOXICITY;

CONCURRENT CHEMORADIOTHERAPY; GEMCETABINE; INDUCTION CHEMOTHERAPY; NON-SMALL-CELL LUNG CANCER;

CHEMOTHERAPY;

AMINOTRANSFERASE; CISPLATIN; ETOPOSIDE; GEMCITABINE; NAVELBINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADENOCARCINOMA; ADULT; AGED; ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; BLOOD TOXICITY; BRONCHOMALACIA; BRONCHUS FISTULA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FATALITY; DRUG TOLERABILITY; ESOPHAGITIS; ESOPHAGUS FISTULA; ESOPHAGUS STRICTURE; FATALITY; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; INFECTION; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MALE; MYALGIA; NAUSEA; NEUROPATHY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION INJURY; RASH; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TRACHEA DISEASE; TRACHEOBRONCHOMALACIA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; VINBLASTINE;

EID: 27144441736     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.04.034     Document Type: Article

References (47)

1. R. Dillman, S. Seagren, K. Propert A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer N Engl J Med 323 1990 940 945
2. T. Le Chevalier, R. Arriagada, E. Quoix Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer First analysis of a randomized trial in 353 patients J Natl Cancer Inst 83 1991 417 423
3. C. Schaake-Koning, W. Vand den Bogaert, O. Dalesio Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer N Engl J Med 326 1992 524 530
4. W. Sause, C. Scott, S. Taylor 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588 Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer J Natl Cancer Inst 87 1995 198 205
5. B. Jeremic, Y. Shibamoto, L. Acimovic Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small cell lung cancer J Clin Oncol 13 1995 452 458
6. K. Furuse, M. Fukuoka, M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer J Clin Oncol 17 1999 2692 2699
7. W. Curran, C. Scott, C. Langer Phase III comparison of sequential versus concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer Report of Radiation Therapy Oncology Group 9410, 9th World Conference on Lung Cancer Lung Cancer 29 2000 93
8. R. Dillman, J. Herndon, S.L. Seagren Improved survival in stage III non-small-cell lung cancer Seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial J Natl Cancer Inst 88 1996 1210 1215
9. B. Jeremic, Y. Shibamoto, L. Acimovic Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer A randomized study J Clin Oncol 14 1996 1065 1070
10. R.W. Byhardt, C. Scott, W.T. Sause Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung Int J Radiat Oncol Biol Phys 42 1998 469 478
11. T. Le Chevalier, D. Brisgand, J. Douillard Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer Results of a European multicenter trial including 612 patients J Clin Oncol 12 1994 360 367
12. L. Crino, G.V. Scagliotti, S. Ricci Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non-small-cell lung cancer A randomized phase III study of the Italian Lung Cancer Project J Clin Oncol 17 1999 3522 3530
13. P. Bonomi, K. Kim, D. Fairclough Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin Results of an Eastern Cooperative Oncology Group trial J Clin Oncol 18 2000 623 631
14. C. Gridelli, C. Gallo, F.A. Shepherd Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer A phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 21 2003 3025 3034
15. K.S. Albain, V.W. Rusch, J.J. Crowley Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer Mature results of Southwest Oncology Group phase II study 8805 J Clin Oncol 13 1995 1880 1892
16. J.S. Lee, C. Scott, R. Komaki Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancer Radiation Therapy Oncology Group protocol 91-06 J Clin Oncol 14 1996 1055 1064
17. F. Reboul, Y. Brewer, P. Vincent Concurrent cisplatin, etoposide, and radiotherapy for unresectable Stage III non-small-cell lung cancer A Phase II study Int J Radiat Oncol Biol Phys 35 1996 343 350
18. C. van Bree, N. Castro Kreder, W.J. Loves Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines Int J Radiat Oncol Biol Phys 54 2002 237 244
19. D.J. Adams, V.C. Knick P-glycoprotein mediated resistance to 5′-nor-anhydro-vinblastine Invest New Drugs 13 1995 13 21
20. M.P. Sunyach, L. Falchero, P. Pommier Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer Preliminary results Int J Radiat Oncol Biol Phys 48 2000 459 463
21. S. Senan, S. Burgers, M.J. Samson Can elective nodal irradiation be omitted in Stage III non-small-cell lung cancer? Analysis of recurrences in a Phase II study of induction chemotherapy and involved-field radiotherapy Int J Radiat Oncol Biol Phys 54 2002 999 1006
22. World Health Organization Handbook for reporting results of cancer treatment (WHO Offset Publication No. 48) 1979 World Health Organization Geneva, Switzerland
23. Arbuck SG, Ivy SP, Setser A, et al. The revised common toxicity criteria: Version 2.0. CTEP Web site: http://ctep.info.nih.gov
24. R. Simon Optimal two-stage designs for phase II clinical trials Control Clin Trials 10 1989 1 10
25. W.J. Curran Jr, P.M. Stafford Lack of apparent difference in outcome between clinically staged IIIA and IIIB non-small-cell lung cancer treated with radiation therapy J Clin Oncol 8 1990 409 415
26. K.S. Albain, V.W. Rusch, J.J. Crowley Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer Mature results of Southwest Oncology Group phase II study 8805 J Clin Oncol 13 1995 1880 1892
27. S. Firat, R.W. Byhardt, E. Gore Radiation Therapy Oncology Group Comorbidity and Karnofsky performance score are independent prognostic factors in Stage III non-small-cell lung cancer An institutional analysis of patients treated on four RTOG studies Int J Radiat Oncol Biol Phys 54 2002 357 364
28. M. Machtay, W. Seiferheld, R. Komaki Is prolonged survival possible for patients with supraclavicular node metastases in non-small-cell lung cancer treated with chemoradiotherapy? Analysis of the Radiation Therapy Oncology Group experience Int J Radiat Oncol Biol Phys 44 1999 847 853
29. I.C. Kiricuta Is prolonged survival possible for patients with supraclavicular node metastases in NSCLC treated with chemoradiotherapy? IJROBP 1999;44:847-853 Int J Radiat Oncol Biol Phys 46 2000 1078 1079
30. E.E. Vokes, J.E. Herndon, J. Crawford Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small cell lung cancer Cancer and Leukemia Group B Study 9431 J Clin Oncol 20 2002 4191 4198
31. E.E. Vokes, J.E. Herndon, M.J. Kelley Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer (NSCLC) Initial analysis of a randomized phase III trial J Clin Oncol 22 2004 618s 2004 ASCO annual meeting proceedings (post-meeting edition)
32. K.S. Albain, J.J. Crowley, A.T. Turrisi 3rd Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small cell lung cancer A Southwest Oncology Group Phase II Study, SWOG 9019 J Clin Oncol 20 2002 3454 3460
33. D.R. Gandara, K. Chansky, K.S. Albain Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small cell lung cancer Phase II Southwest Oncology Group study S9504 J Clin Oncol 21 2003 2004 2010
34. J.G. Rosenman, J.S. Halle, M.A. Socinski High-dose conformal radiotherapy for treatment of Stage IIIA/IIIB non-small-cell lung cancer Technical issues and results of a Phase I/II trial Int J Radiat Oncol Biol Phys 54 2002 348 356
35. R. Rengan, K.E. Rosenzweig, E. Venkatraman Improved local control with higher doses of radiation in large-volume Stage III non-small-cell lung cancer Int J Radiat Oncol Biol Phys 60 2004 741 747
36. M.A. Socinski, D.E. Morris, J.S. Halle Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer A dose-escalation phase I trial J Clin Oncol 22 2004 4341 4350
37. H. Murshed, H.H. Liu, Z. Liao Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer Int J Radiat Oncol Biol Phys 58 2004 1258 1267
38. P. Scalliet, C. Goor, D. Galdermans Gemzar (gemcitabine) with thoracic radiotherapy A phase II pilot study in chemonaive patients with advanced non-small cell lung cancer (NSCLC) Proc Am Soc Clin Oncol 17 1998 a1923
39. H. Groen, A. Gregor, J. van Putten Phase I trial of gemcitabine and high dose thoracic radiation in stage III non small cell lung cancer Proc Am Soc Clin Oncol 19 2000 a2123
40. S.M. Keller, S. Adak, H. Wagner Eastern Cooperative Oncology Group A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer N Engl J Med 343 2000 1217 1222
41. H. Choy, K. LaPorte, E. Knill-Selby Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer Semin Radiat Oncol 9 1999 90 96
42. J.S. Lee, R. Komaki, F.V. Fossella A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer A 5-year follow-up report Int J Radiat Oncol Biol Phys 42 1998 479 486
43. R. Komaki, C. Scott, J.S. Lee Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung cancer (NSCLC) Comparison of RTOG 83-11 and RTOG 91-06 Am J Clin Oncol 20 1997 435 440
44. C.J. Langer, C. Hsu, W. Curran Do elderly patients with locally advanced non-small-cell lung cancer (NSCLC) benefit from combined modality therapy? A secondary analysis of RTOG 94-10 Int J Radiat Oncol Biol Phys 51 2001 20 21
45. M. Roach III, D.R. Gandara, H.S. Yuo Radiation pneumonitis following combined modality therapy for lung cancer Analysis of prognostic factors J Clin Oncol 13 1995 2606 2612
46. R. Komaki, J.S. Lee, L. Milas Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer Report of a randomized comparative trial Int J Radiat Oncol Biol Phys 58 2004 1369 1377
47. H.H. Liu, X. Wang, L. Dong Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 58 2004 1268 1279